1366067-23-3

Basic information

• Product Name: 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid
• Synonyms: 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid
• CAS NO: 1366067-23-3
• Molecular Weight: 414.48
• Mol File: 1366067-23-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid(1366067-23-3)
• EPA Substance Registry System: 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid(1366067-23-3)

Safety Data

• Hazardous Substances Data: 1366067-23-3(Hazardous Substances Data)

Upstream product

• 1366067-89-1 benzyl 3-(2-dipropylcarbamoylmethoxycarbonylethylsulfamoyl)benzoic acid benzyl ester 
• 1366067-80-2 3-benzyloxycarbonylaminopropionic acid dipropylcarbamoylmethyl ester 
• 1391750-97-2 3-tert-butoxycarbonylaminopropionic acid dipropylcarbamoylmethyl ester 
• 2315-37-9 2-chloro-N,N-dipropylacetamide 
• 1366067-84-6 3-amino-propionic acid dipropylcarbamoylmethyl ester 
• 4025-64-3 3-Carboxybenzenesulfonyl chloride 

Downstream Products

• 1366295-61-5 3-(3-{2-[(E)-3,5-diamino-6-chloropyrazine-2-carbonylimino]-1,3,8-triazaspiro[4.5]decane-8-carbonyl}benzenesulfonylamino)propionic acid dipropylcarbamoylmethyl ester 
• 1458672-32-6 3-(3-{2-[(E)-3,5-diamino-6-chloropyrazine-2-carbonylimino]-1,3,8-triazaspiro[4.5]decane-8-carbonyl}benzenesulfonylamino)propionic acid dipropylcarbamoylmethyl ester succinate salt 

Relevant articles and documents

PYRAZINE DERIVATIVES AS ENAC BLOCKERS

Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

PYRAZINE DERIVATIVES AS ENAC BLOCKERS

Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.